GlassScriptPhysician profile
Christopher Matthew Manning
NPI 1689654709
$714.45
in general payments reported to CMS, 2019-2025
12 companies · $210 in 2025
The $210 reported for 2025 was less than what a typical Hand Surgery provider received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $43.47 · 2020: $19.45 · 2021: $13.38 · 2022: $289 · 2023: $42.83 · 2024: $96.65 · 2025: $210.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $349.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $349.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $169.10 | 2022 | |
| Stryker Corporation | $119.63 | 2022 | |
| Bioventus LLC | $91.25 | 2023-2025 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Depuy Synthes Sales INC. | $82.01 | 2025 | Motoband, Orthovisc, Monovisc |
| Ethicon US, LLC | $64.49 | 2025 | Monocryl, Harmonic, Enseal |
| Axogen | $49.62 | 2024 | Axoguard Ha+ Nerve Protector, Axoguard Nerve Protector, Axoguard Nerve Cap |
| Horizon Therapeutics Plc | $32.83 | 2020-2021 | |
| Smith+Nephew, INC. | $29.26 | 2025 | Stravix Mesh |
| Pacira Pharmaceuticals Incorporated | $23.41 | 2019 | |
| Medtronic USA, INC. | $20.06 | 2019 | |
| Baxter Healthcare | $19.29 | 2023 | Floseal |
| Amgen INC. | $13.50 | 2025 | Krystexxa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Manning listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.